DSV, 590 - Share Buyback in DSV A/S and reduction of share

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DSV, 590 - Share Buyback in DSV A/S and reduction of share capital in DSV A/S

Reduction of share capital

At DSV's Annual General Meeting on 12 March 2015 a resolution was passed, following a proposal by the Board of Directors, to reduce the share capital by a nominal amount of DKK 2,000,000 through the cancellation of 2,000,000 treasury shares, corresponding to 2,000,000 voting rights. 

The announcement of the resolution was published through the IT information system of the Danish Business Authority on 13 March 2015. 

At the expiry of the four-week time limit on 11 April 2015, no claims had been filed requiring satisfaction or provision of security, and the reduction and registration of the share capital has consequently been completed on 13 April 2015.

Consequently, the share capital of DSV has a nominal value of DKK 175,000,000, divided into 175,000,000 shares with a face value of DKK 1, corresponding to 175,000,000 voting rights.

Share buy-back On 19 February 2015, DSV A/S initiated the previously announced share buy-back programme, cf. company announcement No. 582 of 6 February 2015. According  to the programme DSV A/S will in the period from 19 February to 22 April 2015 purchase own shares up to a maximum value of DKK 200,000,000 and no more than 1,500,000 shares, corresponding to 0.85% of the share capital of DSV A/S at that time. The programme has been implemented in accordance with the 'Safe Harbour' provisions of EU Regulation No. 2273/2003 of 22 December 2003. DSV will therefore publish the accumulated purchases under the share buy-back programme every 7th trading day.    

Trading day   Number of shares bought back Average transaction price Amount  DKK
Accumulated for trading days 1-28 600,995 215.10 129,275,893
29: 31 March 2015 23,000 217.56 5,003,979
30: 1 April 2015 20,000 217.69 4,353,882
31: 7 April 2015 28,000 223.26 6,251,331
32: 8 April 2015 23,000 224.91 5,172,900
33: 9 April 2015 16,500 225.66 3,723,469
34: 10 April 2015 25,000 232.80 5,820,000
35: 13 April 2015 16,000 230.80 3,692,861
Accumulated for trading days 1-35 752,495 217.00 163,294,315

As at today, DSV A/S holds a total of 5,469,792 shares of a nominal value of DKK 1 in DSV A/S, corresponding to 3.13% of the total number of issued shares of 175,000,000. Any questions may be addressed to Flemming Ole Nielsen, Director, Investor Relations, on tel. +45 43 20 33 92.

Yours sincerely,

DSV A/S

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Triumph Financial Sets Stage for Q4 Earnings and Insights

Updated Category News Views 196

Triumph Financial Plans Fourth Quarter Earnings Release Triumph Financial, Inc. (Nasdaq: TFIN) recently announced its anticipation for the release of fourth quarter financial results. This event is scheduled to take place after the market closes on an upcoming Wednesday. Along with the financial report, the company will provide management commentary for stakeholders and...

Continue Reading
Monitoring ABA Therapy Progress: A Parent's Guide

Updated Category News Views 6

The Nuts and Bolts of Progress Monitoring You've got a situation in Leominster where parents are trying to make sense of ABA therapy's impact on their kids. Rob Shapiro, a big name in the ABA world, breaks it all down in a HelloNation article. We're talking about precise data collection being the backbone of measuring progress in ABA therapy. This ain't no place for...

Continue Reading
Understanding Dowlais Group's Recent Market Activities

Updated Category News Views 185

Public Disclosure Regarding Dowlais Group's Trading Activity FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree in relation to whose r

Continue Reading
OFS Credit Company Reports Impressive Q4 Financials for 2024

Updated Category News Views 98

OFS Credit Company Delivers Strong Q4 2024 Financial Results OFS Credit Company, Inc. (NASDAQ: OCCI), a notable investment firm focusing on collateralized loan obligation (CLO) equity and debt securities, has announced its financial performance for the fiscal quarter ending October 31, 2024. This report outlines the company’s significant financial growth and strategic...

Continue Reading
Breakthrough Data on HBI-8000 and Nivolumab for Melanoma

Updated Category News Views 89

HBI-8000 and Nivolumab: A New Era in Melanoma Treatment Recent findings highlight the potential of HBI-8000 in combination with nivolumab, suggesting a transformative approach in the treatment of advanced melanoma. This promising combination will be discussed in detail at an upcoming prestigious annual meeting focused on advancements in immunotherapy. Innovative Solutions...

Continue Reading